Nasdaq IPOs

Finch Therapeutics Group, a Phase 3-ready biotech developing microbiome therapeutics, raised $128 million by offering 7.5 million shares at $17, the high end of the range of $15 to $17. The company offered 1.3 million more shares than anticipated. Finch is a microbiome therapeut

Instil Bio, an early stage biotech developing immune cell therapies for cancer, raised $320 million by offering 16 million shares at $20, the high end of the upwardly revised range of $19 to $20. The company had originally planned to offer 13.9 million shares at a range of $

Connect Biopharma Holdings, a Chinese Phase 2 biotech developing therapies for T cell-driven inflammatory diseases, raised $191 million by offering 11.3 million ADSs at $17, the high end of the range of $15 to $17. The company offered 1.9 million more ADSs than anticipated. At pr

Longview Acquisition II, the second blank check company formed by executives at healthcare-focused hedge fund Glenview Capital, raised $600 million by offering 60 million units at $10. The company offered 10 million more units than anticipated. Each unit consists of one share of

Levere Holdings, a blank check company formed by Goggo Network and auto-tech execs targeting the EMEA mobility sector, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50.

LDH Growth I, the second blank check company formed by SoftBank targeting technology-enabled sectors, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-fifth of a warrant, exercisable at $11.50. The company may r

BYTE Acquisition, a blank check company targeting the Israeli technology industry, raised $300 million by offering 30 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. The company is led by Executive Chai

AF Acquisition, a blank check company targeting the food and beverage, wellness, beauty, pet, and personal care sectors, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50

Glenfarne Merger, a blank check company formed by Glenfarne Group targeting energy transition and electrification, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The

CAVU Technology Acquisition, a blank check company formed by the co-founders of CAVU Capital targeting tech, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The Tampa, FL-based company plans to raise $100 million by offering 10 million u

Good Works II Acquisition, a blank check company targeting high-growth businesses, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The Houston, TX-based company plans to raise $200 million by offering 20 million units at $10. Each unit c

Healthcare Merger II, a blank check company led by Steven Shulman and William Sanger targeting the healthcare industry, filed on Thursday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offerin

Quiet Plus I Acquisition, a blank check company formed by Quiet Capital targeting the tech sector, filed on Thursday with the SEC to raise up to $250 million in an initial public offering. The Seattle, WA-based company plans to raise $250 million by offering 25 million units at

agilon health, which provides a senior-focused value-based care platform for primary care physicians, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. Capitalizing on emerging value-based care opportunities, agilon's model provides the ne

The Renaissance International IPO Index (Ticker: IPOXUS), the underlying index for the Renaissance International IPO ETF (Ticker: IPOS), will implement the following constituent changes effective Monday, March 22, 2021: Additions: AUTO1 Group Akeso Blue Moon Group CSN Miner

Instil Bio, an early stage biotech developing immune cell therapies for cancer, raised the proposed deal size for its upcoming IPO on Thursday. The Dallas, TX-based company now plans to raise $312 million by offering 16 million shares at a price range of $19 to $20. The company

CHW Acquisition, a blank check company targeting consumer products and retail, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The Purchase, NY-based company plans to raise $100 million by offering 10 million units at $10. Each unit will

Red Cell DRM Acquisition, a blank check company targeting businesses driving the electrical power grid transition, filed on Thursday with the SEC to raise up to $250 million in an initial public offering. The Beverly Hills, CA-based company plans to raise $250 million by offerin

Olink Holding, which provides a platform of proteome analysis products for biomedical research, announced terms for its IPO on Thursday. The Uppsala, Sweden-based company plans to raise $300 million by offering 17.6 million ADSs (25% insider) at a price range of $16 to $18.&nbsp

Keter1 Acquisition, a blank check company targeting technology companies in Israel, filed on Thursday with the SEC to raise up to $250 million in an initial public offering. The Claymont, DE-based company plans to raise $250 million by offering 25 million units at $10. Each unit